Literature DB >> 32772496

Oral symptoms and lesions in SARS-CoV-2-positive patient.

Ana Glavina1, Dolores Biočina-Lukenda1, Marinka Mravak-Stipetić2, Jasenka Markeljević3.   

Abstract

Entities:  

Keywords:  SARS-CoV-2; herpes simplex virus; oral lesions; oral symptoms

Mesh:

Year:  2020        PMID: 32772496      PMCID: PMC7436399          DOI: 10.1111/odi.13596

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   4.068


× No keyword cloud information.
Dear Editor‐in‐Chief Professor Lodi, We would like to contribute to the oral manifestations of SARS‐CoV‐2 infection due to the small number of case reports described and confusing data from the available literature. Previous data from the literature describe heterogeneous signs and symptoms on the oral mucosa: dysgeusia or ageusia, desquamative gingivitis, erythema exudativum multiforme (EEM), salivary gland infections, xerostomia, necrotizing periodontal disease (NPD), non‐specific erythematous lesions, recurrent herpes simplex virus (HSV) infection, and vesiculobullous lesions (Martín Carreras ‐ Presas et al., 2020; Galván Casas et al., 2020; Jimenez‐Cauhe et al., 2020; Sinadinos and Shelswell, 2020; Patel and Woolley, 2020; Petrescu, Lucaciu, & Roman, 2020; Al‐Khatib, 2020; Passarelli, Lopez, Bonaviri, Garcia‐Godoy, & D'Addona, 2020; Abu‐Hammad, Dar‐Odeh, & Abu‐Hammad, 2020; Chaux‐Bodard, Deneuve, & Desoutter, 2020). Such results should be interpreted with caution so as not to create unnecessary concern among physicians, dentists, and patients. A short communication by Martín Carreras‐Presas et al. (2020) described oral lesions in patients with suspected SARS‐CoV‐2 infection, so it is not possible to draw conclusions about a causal relationship. To date, acute ageusia is the most significant symptom in the oral cavity that can raise suspicion of early SARS‐CoV‐2 infection. We would like to present oral manifestations in a 40‐year‐old dental assistant with confirmed SARS‐CoV‐2 infection by polymerase chain reaction (PCR). She was suspected of SARS‐CoV‐2 infection due to initial symptoms of general weakness, mild fever (37.2°C), and acute loss of taste sensation. Despite the relatively mild symptoms, she was referred for testing (PCR) at the Clinical Hospital Center Split due to the nature of her work. She had no associated comorbidities and was not taking any medications. The patient only reported frequent eruptions of recurrent herpes labialis (RHL). She felt pain and burning in the oral cavity seven days after the confirmation of SARS‐CoV‐2 infection. An oral medicine specialist was telemedically consulted. Clinical oral examination was performed through video consultation and attached photographs. Clinical oral findings showed recurrent HSV of the hard palate (Figure 1), white hairy tongue (lingua villosa alba), and non‐specific white lesions of the ventral side of the tongue. The patient was prescribed systemic acyclovir therapy (Virolex® tbl 200 mg, five times a day for 5 days) and local therapy (antiseptic, nystatin, panthenol, local anesthetic) for 2 weeks. The therapy was delivered to her home address in compliance with disinfection measures. The patient's recovery lasted three weeks, and the healing was confirmed by a double negative PCR test.
Figure 1

Recurrent herpes simplex virus (HSV) of the hard palate

Recurrent herpes simplex virus (HSV) of the hard palate We are of the opinion that the acute loss of taste in our patient is caused by the new coronavirus. Lesions of recurrent HSV of the hard palate mucosa are not caused, but triggered by SARS‐CoV‐2 infection. Recurrent oral HSV infection is likely to be stress‐induced and is a secondary manifestation of the host's compromised immune system. Clinical oral examination should be a standard part of the protocol of hospitalized patients with confirmed SARS‐CoV‐2 infection. Further studies are needed to determine whether the new coronavirus is the cause or predisposing factor for the development of oral symptoms and lesions. I look forward to hearing from you at your earlier convenience. Yours sincerely, Ana Glavina.

CONFLICT OF INTEREST

Authors declare they have no conflict of interest.

AUTHOR CONTRIBUTIONS

Ana Glavina: Resources; Writing‐original draft. Dolores Biočina‐Lukenda: Supervision; Writing‐review & editing. Marinka Mravak‐Stipetic: Supervision; Writing‐review & editing. Jasenka Katarina Markeljević: Supervision; Writing‐review & editing.

PEER REVIEW

The peer review history for this article is available at https://publons.com/publon/10.1111/odi.13596.
  9 in total

Review 1.  Taste and smell as chemosensory dysfunctions in COVID-19 infection.

Authors:  Pier Carmine Passarelli; Michele Antonio Lopez; Giuseppe Niccolò Mastandrea Bonaviri; Franklin Garcia-Godoy; Antonio D'Addona
Journal:  Am J Dent       Date:  2020-06       Impact factor: 1.522

2.  Oral manifestations in COVID-19 patients.

Authors:  Aceil Al-Khatib
Journal:  Oral Dis       Date:  2020-07-07       Impact factor: 4.068

3.  Oral mucosa lesions in COVID-19.

Authors:  Nausica Petrescu; Ondine Lucaciu; Alexandra Roman
Journal:  Oral Dis       Date:  2020-07-07       Impact factor: 4.068

4.  Oral vesiculobullous lesions associated with SARS-CoV-2 infection.

Authors:  Carmen Martín Carreras-Presas; Juan Amaro Sánchez; Antonio Francisco López-Sánchez; Enric Jané-Salas; Maria Luisa Somacarrera Pérez
Journal:  Oral Dis       Date:  2020-05-29       Impact factor: 4.068

5.  Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.

Authors:  C Galván Casas; A Català; G Carretero Hernández; P Rodríguez-Jiménez; D Fernández-Nieto; A Rodríguez-Villa Lario; I Navarro Fernández; R Ruiz-Villaverde; D Falkenhain-López; M Llamas Velasco; J García-Gavín; O Baniandrés; C González-Cruz; V Morillas-Lahuerta; X Cubiró; I Figueras Nart; G Selda-Enriquez; J Romaní; X Fustà-Novell; A Melian-Olivera; M Roncero Riesco; P Burgos-Blasco; J Sola Ortigosa; M Feito Rodriguez; I García-Doval
Journal:  Br J Dermatol       Date:  2020-06-10       Impact factor: 11.113

6.  Necrotizing periodontal disease: Oral manifestation of COVID-19.

Authors:  Jay Patel; Julian Woolley
Journal:  Oral Dis       Date:  2020-06-22       Impact factor: 4.068

7.  Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings.

Authors:  J Jimenez-Cauhe; D Ortega-Quijano; I Carretero-Barrio; A Suarez-Valle; D Saceda-Corralo; C Moreno-Garcia Del Real; D Fernandez-Nieto
Journal:  Clin Exp Dermatol       Date:  2020-06-25       Impact factor: 4.481

8.  Oral ulceration and blistering in patients with COVID-19.

Authors:  Angela Sinadinos; Jonathan Shelswell
Journal:  Evid Based Dent       Date:  2020-06

9.  SARS-CoV-2 and oral ulcers: A causative agent or a predisposing factor?

Authors:  Shaden Abu-Hammad; Najla Dar-Odeh; Osama Abu-Hammad
Journal:  Oral Dis       Date:  2020-07-13       Impact factor: 4.068

  9 in total
  11 in total

1.  [Translated article] Oral Findings in Patients With COVID-19.

Authors:  M Villarroel-Dorrego; L Chacón; R Rosas; V Barrios; Y Pernía; H Vélez
Journal:  Actas Dermosifiliogr       Date:  2022-02

2.  Oro-facial mucocutaneous manifestations of Coronavirus Disease-2019 (COVID-19): A systematic review.

Authors:  Kausar Sadia Fakhruddin; Lakshman Perera Samaranayake; Borvornwut Buranawat; Hien Ngo
Journal:  PLoS One       Date:  2022-06-01       Impact factor: 3.752

3.  An update on oral clinical courses among patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A clinical follow-up (a prospective prevalent cohort) study.

Authors:  Heron Gezahegn Gebretsadik
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

Review 4.  An integrative review of oral manifestations in patients with COVID-19: signs directly related to SARS-CoV-2 infection or secondary findings?

Authors:  Vanessa Paiva Reis; Adriana Raymundo Bezerra; Adriane Batista Pires Maia; Letícia Côgo Marques; Danielle Castex Conde
Journal:  Int J Dermatol       Date:  2021-09-19       Impact factor: 3.204

Review 5.  COVID-19 and oral lesions, short communication and review.

Authors:  Sonia Egido-Moreno; Joan Valls-Roca-Umbert; Enric Jané-Salas; José López-López; Albert Estrugo-Devesa
Journal:  J Clin Exp Dent       Date:  2021-03-01

Review 6.  Antiviral performance of graphene-based materials with emphasis on COVID-19: A review.

Authors:  Tahereh Seifi; Ali Reza Kamali
Journal:  Med Drug Discov       Date:  2021-05-25

Review 7.  Is SARS-CoV-2 an Etiologic Agent or Predisposing Factor for Oral Lesions in COVID-19 Patients? A Concise Review of Reported Cases in the Literature.

Authors:  Shahroo Etemad-Moghadam; Mojgan Alaeddini
Journal:  Int J Dent       Date:  2021-05-18

Review 8.  COVID-19 from the perspective of dentists: A case report and brief review of more than 170 cases.

Authors:  Reyhaneh Eghbali Zarch; Pegah Hosseinzadeh
Journal:  Dermatol Ther       Date:  2021-01-01       Impact factor: 3.858

Review 9.  Covid-19 and oral diseases: Crosstalk, synergy or association?

Authors:  Daniela A Brandini; Aline S Takamiya; Pari Thakkar; Samantha Schaller; Rani Rahat; Afsar R Naqvi
Journal:  Rev Med Virol       Date:  2021-03-01       Impact factor: 11.043

10.  [Oral Findings in Patients With COVID-19].

Authors:  M Villarroel-Dorrego; L Chacón; R Rosas; V Barrios; Y Pernía; H Vélez
Journal:  Actas Dermosifiliogr       Date:  2021-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.